The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Psoriasis Pathogenesis and Treatment
Open accessAbstract
Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been translated into targeted and highly effective therapies providing fundamental insights into the pathogenesis of chronic inflammatory diseases with a dominant IL-23/Th17 axis. This review discusses the mechanisms involved in the initiation and development of the disease, as well as the therapeutic options that have arisen from the dissection of the inflammatory psoriatic pathways. Our discussion begins by addressing the inflammatory pathways and key cell types initiating and perpetuating psoriatic inflammation. Next, we describe the role of genetics, associated epigenetic mechanisms, and the interaction of the skin flora in the pathophysiology of psoriasis. Finally, we include a comprehensive review of well-established widely available therapies and novel targeted drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.339 · Cited by 2,592
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997 · cited 1×
“Candida infections are more frequent in patients receiving anti-IL17 biologics secukinumab and ixekizumab compared to etanercept [209].”
BackgroundRisk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
for the Collaborative Association Study of Psoriasis, Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., Gudjonsson, J. E., Li, Y., Tejasvi, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.311 · Cited by 1,409
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,124
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Identification of a second human retinoic acid receptor
Brand, N., Petkovich, M., Krust, A., Chambon, P., de Thé, H., Marchio, A., Tiollais, P., & Dejean, A. (1988) · Nature · doi:10.1038/332850a0 · Cited by 1,022
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
Psoriasis − epidemiology and clinical spectrum
Christophers, E. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00832.x · Cited by 972
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Definition of treatment goals for moderate to severe psoriasis: a European consensus
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., et al. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1080-1 · Cited by 898
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Randazzo, B., Wasfi, Y., Shen, Y.-K., Li, S., & Kimball, A. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.041 · Cited by 897
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 848
Psoriasis prevalence among adults in the United States
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.013 · Cited by 783
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 728
Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., Hu, C., Stevens, R. M., Day, R. M., Gordon, K. B., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.049 · Cited by 678
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Molecular analysis of human forearm superficial skin bacterial biota
Gao, Z., Tseng, C.-H., Pei, Z., & Blaser, M. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607077104 · Cited by 657
Gomez, J. A., Wapinski, O. L., Yang, Y. W., Bureau, J.-F., Gopinath, S., Monack, D. M., Chang, H. Y., Brahic, M., & Kirkegaard, K. (2013) · Cell · doi:10.1016/j.cell.2013.01.015 · Cited by 627
The immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
The Natural History of Psoriasis in 5,600 Patients
Farber, E. M., & Nall, L. (1974) · Dermatology · doi:10.1159/000251595 · Cited by 599
Reich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
Thaçi, D., Blauvelt, A., Reich, K., Tsai, T.-F., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Hugot, S., You, R., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.013 · Cited by 551
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 539
de Cid, R., Riveira-Munoz, E., Zeeuwen, P. L. J. M., Robarge, J., Liao, W., Dannhauser, E. N., Giardina, E., Stuart, P. E., Nair, R., Helms, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.313 · Cited by 534
Onoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Mease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508
Trembath, R. C., Lee Clough, R., Rosbotham, J. L., Jones, A. B., Camp, R. D. R., Frodsham, A., Browne, J., Barber, R., Terwilliger, J., Mark Lathrop, G., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.5.813 · Cited by 508
Zhang, F., Meng, G., & Strober, W. (2008) · Nature Immunology · doi:10.1038/ni.1663 · Cited by 500
Getting under the skin: the immunogenetics of psoriasis
Bowcock, A. M., & Krueger, J. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1689 · Cited by 484
Armstrong, E. J., Harskamp, C. T., & Armstrong, A. W. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000062 · Cited by 470
Papp, K. A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R. G., Cather, J., Gottlieb, A. B., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14493 · Cited by 470
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Hayter, S. M., & Cook, M. C. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.001 · Cited by 464
Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions
Gao, Z., Tseng, C.-H., Strober, B. E., Pei, Z., & Blaser, M. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002719 · Cited by 451
European consensus statement on phenotypes of pustular psoriasis
Navarini, A. A., Burden, A. D., Capon, F., Mrowietz, U., Puig, L., Köks, S., Kingo, K., Smith, C., Barker, J. N., & the ERASPEN Network (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14386 · Cited by 450
Ahlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Community differentiation of the cutaneous microbiota in psoriasis
Alekseyenko, A. V., Perez-Perez, G. I., De Souza, A., Strober, B., Gao, Z., Bihan, M., Li, K., Methé, B. A., & Blaser, M. J. (2013) · Microbiome · doi:10.1186/2049-2618-1-31 · Cited by 441
The Risk of Stroke in Patients with Psoriasis
Gelfand, J. M., Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., & Troxel, A. B. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.112 · Cited by 439
Gene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17q
Tomfohrde, J., Silverman, A., Barnes, R., Fernandez-Vina, M. A., Young, M., Lory, D., Morris, L., Wuepper, K. D., Stastny, P., Menter, A., et al. (1994) · Science · doi:10.1126/science.8178173 · Cited by 426
PSORS2 Is Due to Mutations in CARD14
Jordan, C. T., Cao, L., Roberson, E. D. O., Pierson, K. C., Yang, C.-F., Joyce, C. E., Ryan, C., Duan, S., Helms, C. A., Liu, Y., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.012 · Cited by 416
Schafer, P., Parton, A., Gandhi, A., Capone, L., Adams, M., Wu, L., Bartlett, J., Loveland, M., Gilhar, A., Cheung, Y., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00559.x · Cited by 406
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
Johnston, A., Xing, X., Wolterink, L., Barnes, D. H., Yin, Z., Reingold, L., Kahlenberg, J. M., Harms, P. W., & Gudjonsson, J. E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.056 · Cited by 397
Prodanovich, S., Kirsner, R. S., Kravetz, J. D., Ma, F., Martinez, L., & Federman, D. G. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.94 · Cited by 394
Warren, R. B., Smith, C. H., Yiu, Z. Z. N., Ashcroft, D. M., Barker, J. N. W. N., Burden, A. D., Lunt, M., McElhone, K., Ormerod, A. D., Owen, C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.208 · Cited by 393
Triggering psoriasis: the role of infections and medications
Fry, L., & Baker, B. S. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.015 · Cited by 384
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
Hüffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., et al. (2010) · Nature Genetics · doi:10.1038/ng.688 · Cited by 371
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
Gregorio, J., Meller, S., Conrad, C., Di Nardo, A., Homey, B., Lauerma, A., Arai, N., Gallo, R. L., DiGiovanni, J., & Gilliet, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101102 · Cited by 367
NF-κB: An essential transcription factor in psoriasis
Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B., & Lizzul, P. F. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.11.002 · Cited by 364
Melanocyte antigen triggers autoimmunity in human psoriasis
Arakawa, A., Siewert, K., Stöhr, J., Besgen, P., Kim, S.-M., Rühl, G., Nickel, J., Vollmer, S., Thomas, P., Krebs, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151093 · Cited by 361
Ellinghaus, D., Ellinghaus, E., Nair, R. P., Stuart, P. E., Esko, T., Metspalu, A., Debrus, S., Raelson, J. V., Tejasvi, T., Belouchi, M., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.020 · Cited by 348
Genome-wide association analysis identifies three psoriasis susceptibility loci
Stuart, P. E., Nair, R. P., Ellinghaus, E., Ding, J., Tejasvi, T., Gudjonsson, J. E., Li, Y., Weidinger, S., Eberlein, B., Gieger, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.693 · Cited by 333
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
Miller, I. M., Ellervik, C., Yazdanyar, S., & Jemec, G. B. E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.053 · Cited by 318
Di Meglio, P., Villanova, F., & Nestle, F. O. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015354 · Cited by 317
Horreau, C., Pouplard, C., Brenaut, E., Barnetche, T., Misery, L., Cribier, B., Jullien, D., Aractingi, S., Aubin, F., Joly, P., et al. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12163 · Cited by 313
Blauvelt, A., Reich, K., Tsai, T.-F., Tyring, S., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R., Hugot, S., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 312
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Gordon, K. B., Duffin, K. C., Bissonnette, R., Prinz, J. C., Wasfi, Y., Li, S., Shen, Y.-K., Szapary, P., Randazzo, B., & Reich, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501646 · Cited by 306
Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin
Fahlén, A., Engstrand, L., Baker, B. S., Powles, A., & Fry, L. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-011-1189-x · Cited by 303
Villani, A. P., Rouzaud, M., Sevrain, M., Barnetche, T., Paul, C., Richard, M.-A., Beylot-Barry, M., Misery, L., Joly, P., Le Maitre, M., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.001 · Cited by 300
Antipsoriatic effect of fumaric acid derivatives
Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., Wassilew, S. W., Horn, T., Kreysel, H. W., Lutz, G., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70121-0 · Cited by 300
Samarasekera, E. J., Neilson, J. M., Warren, R. B., Parnham, J., & Smith, C. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.149 · Cited by 298
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.
Leung, D. Y., Travers, J. B., Giorno, R., Norris, D. A., Skinner, R., Aelion, J., Kazemi, L. V., Kim, M. H., Trumble, A. E., & Kotb, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118263 · Cited by 295
Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Danielsen, K., Olsen, A. O., Wilsgaard, T., & Furberg, A.-S. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12230 · Cited by 278
Papp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R. G., Krueger, J. G., Gottlieb, A. B., Nakagawa, H., Bowman, E. P., Mehta, A., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13932 · Cited by 276
Wu, R., Zeng, J., Yuan, J., Deng, X., Huang, Y., Chen, L., Zhang, P., Feng, H., Liu, Z., Wang, Z., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97426 · Cited by 271
Di Meglio, P., Di Cesare, A., Laggner, U., Chu, C.-C., Napolitano, L., Villanova, F., Tosi, I., Capon, F., Trembath, R. C., Peris, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017160 · Cited by 262
Cheung, K. L., Jarrett, R., Subramaniam, S., Salimi, M., Gutowska-Owsiak, D., Chen, Y.-L., Hardman, C., Xue, L., Cerundolo, V., & Ogg, G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160258 · Cited by 249
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome
Joyce, C. E., Zhou, X., Xia, J., Ryan, C., Thrash, B., Menter, A., Zhang, W., & Bowcock, A. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr331 · Cited by 246
Selectivity and therapeutic inhibition of kinases: to be or not to be?
Ghoreschi, K., Laurence, A., & O'Shea, J. J. (2009) · Nature Immunology · doi:10.1038/ni.1701 · Cited by 241
Psoriasis: a mixed autoimmune and autoinflammatory disease
Liang, Y., Sarkar, M. K., Tsoi, L. C., & Gudjonsson, J. E. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.07.007 · Cited by 239
Antimicrobial peptides in the pathogenesis of psoriasis
MORIZANE, S., & GALLO, R. L. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01483.x · Cited by 237
Morizane, S., Yamasaki, K., Mühleisen, B., Kotol, P. F., Murakami, M., Aoyama, Y., Iwatsuki, K., Hata, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.259 · Cited by 234
Tsoi, L. C., Iyer, M. K., Stuart, P. E., Swindell, W. R., Gudjonsson, J. E., Tejasvi, T., Sarkar, M. K., Li, B., Ding, J., Voorhees, J. J., et al. (2015) · Genome Biology · doi:10.1186/s13059-014-0570-4 · Cited by 233
Li, R., Sun, J., Ren, L.-M., Wang, H.-Y., Liu, W.-H., Zhang, X.-W., Chen, S., Mu, R., He, J., Zhao, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/ker370 · Cited by 232
Boutet, M.-A., Nerviani, A., Gallo Afflitto, G., & Pitzalis, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020530 · Cited by 226
Skin disease and socioeconomic conditions in rural Africa: Tanzania
GIBBS, S. (1996) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1996.tb03687.x · Cited by 225
Hänsel, A., Günther, C., Ingwersen, J., Starke, J., Schmitz, M., Bachmann, M., Meurer, M., Rieber, E. P., & Schäkel, K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.009 · Cited by 223
Self-citationMehta, N. N. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.119 · Cited by 223
MicroRNAs and potential target interactions in psoriasis
Zibert, J. R., Løvendorf, M. B., Litman, T., Olsen, J., Kaczkowski, B., & Skov, L. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.03.004 · Cited by 221
Lizzul, P. F., Aphale, A., Malaviya, R., Sun, Y., Masud, S., Dombrovskiy, V., & Gottlieb, A. B. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23735.x · Cited by 212
Tsai, T.-F., Ho, J.-C., Song, M., Szapary, P., Guzzo, C., Shen, Y.-K., Li, S., Kim, K.-J., Kim, T.-Y., Choi, J.-H., et al. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.05.005 · Cited by 212
Clinical improvement in psoriasis with specific targeting of interleukin-23
Kopp, T., Riedl, E., Bangert, C., Bowman, E. P., Greisenegger, E., Horowitz, A., Kittler, H., Blumenschein, W. M., McClanahan, T. K., Marbury, T., et al. (2015) · Nature · doi:10.1038/nature14175 · Cited by 210
Xu, N., Meisgen, F., Butler, L. M., Han, G., Wang, X.-J., Söderberg-Nauclér, C., Ståhle, M., Pivarcsi, A., & Sonkoly, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202695 · Cited by 208
Yin, X., Low, H. Q., Wang, L., Li, Y., Ellinghaus, E., Han, J., Estivill, X., Sun, L., Zuo, X., Shen, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7916 · Cited by 204
Wan, J., Wang, S., Haynes, K., Denburg, M. R., Shin, D. B., & Gelfand, J. M. (2013) · BMJ · doi:10.1136/bmj.f5961 · Cited by 202
Sampogna, F., Tabolli, S., & Abeni, D. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1273 · Cited by 197
IL-12 protects from psoriasiform skin inflammation
Kulig, P., Musiol, S., Freiberger, S. N., Schreiner, B., Gyülveszi, G., Russo, G., Pantelyushin, S., Kishihara, K., Alessandrini, F., Kündig, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms13466 · Cited by 197
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
Tian, S., Krueger, J. G., Li, K., Jabbari, A., Brodmerkel, C., Lowes, M. A., & Suárez-Fariñas, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044274 · Cited by 183
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Gillard, G. O., Collette, B., Anderson, J., Chao, J., Scannevin, R. H., Huss, D. J., & Fontenot, J. D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.006 · Cited by 173
Revicki, D., Willian, M. K., Saurat, J.-H., Papp, K. A., Ortonne, J.-P., Sexton, C., & Camez, A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08236.x · Cited by 168
Fleming, P., Bai, J., Pratt, M. E., Sibbald, C. J., Lynde, C. W., & Gulliver, W. P. F. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13891 · Cited by 166
A Subset of Methylated CpG Sites Differentiate Psoriatic from Normal Skin
Roberson, E. D. O., Liu, Y., Ryan, C., Joyce, C. E., Duan, S., Cao, L., Martin, A., Liao, W., Menter, A., & Bowcock, A. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.348 · Cited by 163
JOHNSTON, A., GUDJONSSON, J. E., SIGMUNDSDOTTIR, H., LOVE, T. J., & VALDIMARSSON, H. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.00600.x · Cited by 159
Lehmann, J. C. U., Listopad, J. J., Rentzsch, C. U., Igney, F. H., von Bonin, A., Hennekes, H. H., Asadullah, K., & Docke, W.-D. F. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700686 · Cited by 158
Targeting miR-21 to Treat Psoriasis
Guinea‐Viniegra, J., Jiménez, M., Schönthaler, H. B., Navarro, R., Delgado, Y., Concha‐Garzón, M. J., Tschachler, E., Obad, S., Daudén, E., & Wagner, E. F. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008089 · Cited by 158
Cantini, F., Nannini, C., Niccoli, L., Petrone, L., Ippolito, G., & Goletti, D. (2017) · Mediators of Inflammation · doi:10.1155/2017/8909834 · Cited by 157
Prevalence and treatment patterns of psoriatic arthritis in the UK
Ogdie, A., Langan, S., Löve, Þ. J., Haynes, K., Shin, D. B., Seminara, N. M., Mehta, N. N., Troxel, A. B., Choi, H. K., & Gelfand, J. M. (2012) · Rheumatology · doi:10.1093/rheumatology/kes324 · Cited by 153
The gut microbiota and inflammatory bowel diseases
Miyoshi, J., & Chang, E. B. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.002 · Cited by 153
Patients with juvenile psoriatic arthritis comprise two distinct populations
Stoll, M. L., Zurakowski, D., Nigrovic, L. E., Nichols, D. P., Sundel, R. P., & Nigrovic, P. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22173 · Cited by 151
Zhao, M., Wang, L.-T., Liang, G., Zhang, P., Deng, X.-J., Tang, Q., Zhai, H., Chang, C., Su, Y., & Lu, Q. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.10.009 · Cited by 150
Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis
Elder, J. (2009) · Genes and Immunity · doi:10.1038/gene.2009.11 · Cited by 148
Diluvio, L., Vollmer, S., Besgen, P., Ellwart, J. W., Chimenti, S., & Prinz, J. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7104 · Cited by 146
Hawkes, J. E., Nguyen, G. H., Fujita, M., Florell, S. R., Duffin, K. C., Krueger, G. G., & O’Connell, R. M. (2016) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.409 · Cited by 139
Kimball, A. B., Gordon, K. B., Fakharzadeh, S., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10901.x · Cited by 134
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis
Joshi, A. A., Lerman, J. B., Aberra, T. M., Afshar, M. S., Teague, H., Rodante, J. A., Krishnamoorthy, P. M., Ng, Q., Aridi, T. G., Salahuddin, T., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309637 · Cited by 130
Fuentes‐Duculan, J., Bonifacio, K. M., Hawkes, J. E., Kunjravia, N., Cueto, I., Li, X., Gonzalez, J., Garcet, S., & Krueger, J. G. (2017) · Experimental Dermatology · doi:10.1111/exd.13378 · Cited by 129
Pasut, G. (2014) · BioDrugs · doi:10.1007/s40259-013-0064-z · Cited by 126
Sugiura, K. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.006 · Cited by 125
Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.015 · Cited by 124
Craiglow, B. G., Boyden, L. M., Hu, R., Virtanen, M., Su, J. C., Rodriguez, G., McCarthy, C., Luna, P. C., Larralde, M., Humphrey, S. R., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.02.034 · Cited by 124
The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events
Egeberg, A., Skov, L., Joshi, A. A., Mallbris, L., Gislason, G., Wu, J. J., Rodante, J. A., Lerman, J. B., Ahlman, M. A., Gelfand, J. M., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.06.028 · Cited by 122
Bagel, J., Duffin, K. C., Moore, A. Y., Ferris, L. K., Siu, K., Steadman, J., Kianifard, F., Nyirady, J., & Lebwohl, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.05.033 · Cited by 119
Gudjonsson, J. E., Kárason, A., Antonsdóttir, A. A., Rúnarsdóttir, E. H., Hauksson, V. B., Upmanyu, R., Gulcher, J. R., Stefánsson, K., & Valdimarsson, H. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05115.x · Cited by 118
Thorleifsdottir, R. H., Sigurdardottir, S. L., Sigurgeirsson, B., Ólafsson, J., Sigurdsson, M. I., Petersen, H., Árnadóttir, S., Gudjonsson, J. E., Johnston, A. W. B., & Valdimarsson, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102834 · Cited by 118
Berki, D. M., Liu, L., Choon, S. E., Burden, A. D., Griffiths, C. E. M., Navarini, A. A., Tan, E. S. T., Irvine, A. D., Ranki, A., Ogo, T., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.288 · Cited by 117
Chatzikyriakidou, A., Voulgari, P. V., Georgiou, I. A., & Drosos, A. A. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02381.x · Cited by 116
Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis
Kimball, A. B., Guérin, A., Latrémouille-Viau, D., Yu, A. P., Gupta, S. R., Bao, Y., & Mulani, P. M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.08.022 · Cited by 115
Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes
Primo, M. N., Bak, R. O., Schibler, B., & Mikkelsen, J. G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.031 · Cited by 113
The Major Psoriasis Susceptibility Locus PSORS1 Is not a Risk Factor for Late-Onset Psoriasis
Allen, M. H., Ameen, H., Veal, C., Evans, J., Ramrakha‐Jones, V. S., Marsland, A. M., Burden, A. D., Griffiths, C. E. M., Trembath, R. C., & Barker, J. N. W. N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23511.x · Cited by 111
Association of psoriasis with stroke and myocardial infarction: meta‐analysis of cohort studies
Xu, T., & Zhang, Y. ‐. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12002 · Cited by 108
Chiricozzi, A., Suárez‐Fariñas, M., Fuentes‐Duculan, J., Cueto, I., Li, K., Tian, S., Brodmerkel, C. M., & Krueger, J. G. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14034 · Cited by 108
Ejarque, R. A., Rittig, A. H., Johansen, C., Kragballe, K., & Iversen, L. (2013) · Experimental Dermatology · doi:10.1111/exd.12128 · Cited by 107
Matsuzaki, G., & Umemura, M. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12560 · Cited by 107
Riveira‐Muñoz, E., He, S.-M., Escaramís, G., Stuart, P. E., Hüffmeier, U., Lee, C., Kirby, B., Oka, A., Giardina, E., Liao, W. J., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.350 · Cited by 105
Molecular characterization of the skin fungal microbiome in patients with psoriasis
TAKEMOTO, A., Cho, O., 優佳, 諸., Sugita, T., & Muto, M. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12739 · Cited by 104
MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis
Løvendorf, M. B., Zibert, J. R., Gyldenløve, M., Røpke, M. A., & Skov, L. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.05.005 · Cited by 102
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Egeberg, A. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610828 · Cited by 101
Fumaric acid therapy for psoriasis: A randomized, double-blind, placebo-controlled study
Nugteren‐Huying, W. M., van der Schroeff, J. G., Hermans, J. J. R., et al. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)80766-9 · Cited by 100
Microbiomic Signatures of Psoriasis: Feasibility and Methodology Comparison
Statnikov, A., Alekseyenko, A. V., Li, Z., Henaff, M., Perez-Perez, G. I., Blaser, M. J., & Aliferis, C. (2013) · Scientific Reports · doi:10.1038/srep02620 · Cited by 95
Psoriasis in Norwegian twins: contribution of genetic and environmental effects
Grjibovski, A. M., Olsen, A., Magnus, P. M., & Harris, J. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02268.x · Cited by 94
Landscape of Long Noncoding RNAs in Psoriatic and Healthy Skin
Gupta, R., Ahn, R. S., Lai, K., Mullins, E., Debbaneh, M. G., Dimon, M. T., Arron, S. T., & Liao, W. J. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.009 · Cited by 94
Xu, L., Leng, H., Shi, X., Ji, J., Fu, J., & Leng, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.105 · Cited by 93
Nieboer, C., de Hoop, D., Langendijk, P. N. J., Loenen, A. C. V., & Gubbels, J. W. (2009) · Dermatologica · doi:10.1159/000247856 · Cited by 92
Stern, R. S., & Huibregtse, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.399 · Cited by 89
Effect of tonsillectomy on psoriasis: A systematic review
Rachakonda, T. D., Dhillon, J. S., Florek, A. G., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.10.013 · Cited by 79
A single‐nucleotide polymorphism of miR‐146a and psoriasis: an association and functional study
Zhang, W., Yi, X., Guo, S., Shi, Q., Wei, C., Li, X., Gao, L., Wang, G., Gao, T., Wang, L., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12359 · Cited by 79
Løvendorf, M. B., Mitsui, H., Zibert, J. R., Røpke, M. A., Hafner, M., Dyring‐Andersen, B., Bonefeld, C. M., Krueger, J. G., & Skov, L. (2014) · Experimental Dermatology · doi:10.1111/exd.12604 · Cited by 78
Santini, S. M., Lapenta, C., Donati, S., Spadaro, F., Belardelli, F., & Ferrantini, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017364 · Cited by 75
Transcriptome classification reveals molecular subtypes in psoriasis
Ainali, C., Valeyev, N. V., Perera, G. K., Williams, A. E., Gudjonsson, J. E., Ouzounis, C. A., Nestle, F. O., & Tsoka, S. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-472 · Cited by 68
Cardiovascular aspects of psoriasis: an updated review
Pietrzak, A., Bartosińska, J., Chodorowska, G., Szepietowski, J. C., Paluszkiewicz, P., & Schwartz, R. A. (2013) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05584.x · Cited by 68
Gesser, B., Johansen, C., Rasmussen, M. K., Funding, A. T., Otkjær, K., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700859 · Cited by 67
Psoriasis Is Not a Useful Independent Risk Factor for Cardiovascular Disease
Stern, R. S. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.446 · Cited by 60
Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway
Bissonnette, R., Fuentes‐Duculan, J., Mashiko, S., Li, X., Bonifacio, K. M., Cueto, I., Suárez‐Fariñas, M., Maari, C., Bolduc, C., Nigen, S., et al. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.09.019 · Cited by 58
Role of psoriasis as independent predictor of cardiovascular disease: A meta-regression analysis
Gaeta, M., Castelvecchio, S., Ricci, C., Pigatto, P. D. M., Pelissero, G., & Cappato, R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.197 · Cited by 57
Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era
Swindell, W. R., Stuart, P. E., Sarkar, M. K., Voorhees, J. J., Elder, J. T., Johnston, A. W. B., & Gudjonsson, J. E. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-27 · Cited by 53
HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment
West, J., Ogston, S., Berg, J., Palmer, C., Fleming, C., Кумар, В., & Foerster, J. (2017) · Clinical and Experimental Dermatology · doi:10.1111/ced.13100 · Cited by 50
Thorleifsdottir, R. H., SIGURDARDOTTIR, S. T., Sigurgeirsson, B., Ólafsson, J., Sigurdsson, M. I., Petersen, H., Gudjonsson, J. E., Johnston, A., & Valdimarsson, H. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2562 · Cited by 49
Mapping of psoriasis to 17q terminus
Hwu, W., Yang, C.-F., Fann, C. S. J., Chen, C.-L., Tsai, T.-F., Chien, Y.-H., Chiang, S.-C., Chen, C.-H., Hung, S.-I., Wu, J.-Y., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018564 · Cited by 48
Bissonnette, R., Haydey, R. P., Rosoph, L. A., Lynde, C. W., Bukhalo, M., Fowler, J. F., Delorme, I., Gagné-Henley, A., Gooderham, M., Poulin, Y. P., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14647 · Cited by 48
Long Noncoding RNA: Significance and Potential in Skin BiologyPreprint
Wan, D. C., & Wang, K. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015404 · Cited by 47
Interleukin 23 in Crohnʼs Disease
Eken, A., Singh, A. K., & Oukka, M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000442014.52661.20 · Cited by 46
Komorbidität bei Psoriasis vulgaris
Gerdes, S., Mrowietz, U., & Boehncke, W. (2016) · Der Hautarzt · doi:10.1007/s00105-016-3805-3 · Cited by 43
Psoriasis and risk of cardiovascular disease: A meta-analysis of cohort studies
Gu, W., Weng, C., Zhao, Y.-T., Liu, Q., & Yin, R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.127 · Cited by 37
Altered bone remodeling in psoriatic arthritis
Mensah, K. A., Schwarz, E. M., & Ritchlin, C. T. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0050-5 · Cited by 35
Gudjonsson, J. E., & Krueger, G. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.364 · Cited by 34
Thorleifsdottir, R. H., Sigurdardottir, S. L., Sigurgeirsson, B., Ólafsson, J., Petersen, H., Sigurdsson, M. I., Gudjonsson, J. E., Johnston, A., & Valdimarsson, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.061 · Cited by 34
Yunusbaeva, M. M., Valiev, R., Bilalov, F. S., Султанова, З. И., Sharipova, L., & Yunusbayev, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-24491-z · Cited by 33
Harper, R. A. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90396-5 · Cited by 31
Lee, J., Youn, J.-I., Kim, T.-Y., Choi, J.-H., Park, C.-J., Choe, Y.-B., Song, H.-J., Kim, K. J., Kim, K.-J., Lee, J., et al. (2016) · BMC Dermatology · doi:10.1186/s12895-016-0048-z · Cited by 31
miR‐424 levels in hair shaft are increased in psoriatic patients
Tsuru, Y., Jinnin, M., Ichihara, A., Fujisawa, A., Moriya, C., Sakai, K., Fukushima, S., & Ihn, H. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12460 · Cited by 26
The Molecular Revolution in Cutaneous Biology: EDC and Locus Control
Oh, I. Y., & Strong, C. D. G. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.03.046 · Cited by 25
Alteraciones en los niveles de expresión del microARN-33 en plasma de pacientes con psoriasis
García‐Rodríguez, S., Arias-Santiago, S., Orgaz‐Molina, J., Magro‐Checa, C., Valenzuela, I., Navarro, P., Naranjo‐Sintes, R., Sancho, J., & Zubiaur, M. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2013.11.010 · Cited by 24
Emerging biomarkers in psoriatic arthritis
Paek, S. Y., Han, L., Weiland, M. J., Lu, C., McKinnon, K. M., Zhou, L., Lim, H. W., Elder, J. T., & Mi, Q. (2015) · IUBMB Life · doi:10.1002/iub.1453 · Cited by 24
Abnormal Levels of Expression of Plasma MicroRNA-33 in Patients With Psoriasis
García‐Rodríguez, S., Arias-Santiago, S., Orgaz‐Molina, J., Magro‐Checa, C., Valenzuela, I., Navarro, P., Naranjo‐Sintes, R., Sancho, J., & Zubiaur, M. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2014.04.003 · Cited by 21
Elder, J. T. (2018) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1016/j.jisp.2018.09.005 · Cited by 20
Oehrl, S., Prakash, H., Ebling, A., Trenkler, N., Wölbing, P., Kunze, A., Döbel, T., Schmitz, M., Enk, A., & Schäkel, K. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.04.005 · Cited by 19
Self-citationOehrl, S., Olaru, F., Kunze, A., Maas, M., Pezer, S., Schmitz, M., & Schäkel, K. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.016 · Cited by 12
Self-citation
Cited by
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04523-3 · Cited by 632
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
The Immunology of Psoriasis-Current Concepts in Pathogenesis
Sieminska, I., Pieniawska, M., & Grzywa, T. M. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08991-7 · Cited by 346
Liu, J., Liu, Z., Pang, Y., & Zhou, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01343-7 · Cited by 219
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Singh, R., Koppu, S., Perche, P. O., & Feldman, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312793 · Cited by 192
Metadata
- Authors
- Rendon, A., & Schäkel, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-23
- Volume
- 20
- Issue
- 6
- Pages
- 1475
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2924895007
- Cited by
- 2,064
- References
- 181
- FWCI
- 54.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.